Rubin Marc

Average Profitability
18.79%
Insider Buys Quantity
14
Insider Buys Sum
$503,071.70
Insider Sells Quantity
5
Insider Sells Sum
$759,245.41

Insider Activity of Rubin Marc

The largest purchase of all time was on 2018-09-21 and amounted to 400000 shares of Titan Pharmaceuticals, Inc. for $100,000.

The largest sale of all time was on 2018-08-30 and amounted to 58100 shares of Galectin Therapeutics Inc. for $353,312.

Biography of Rubin Marc

No biography is available at this moment.

2019-02-22SaleGalectin Therapeutics Inc.
GALT
director
859
0.002%
$6.02$5,175-31.62%
2019-02-21SaleGalectin Therapeutics Inc.
GALT
director
50,326
0.1119%
$6.02$303,026-35.96%
2019-01-23SaleCuris, Inc.
CRIS
director
18,500
0.0549%
$1.05$19,477+68.22%
2018-09-21PurchaseTitan Pharmaceuticals, Inc.
TTNP
Executive Chairman
400,000
2.107%
$0.25$100,000+10.23%
2018-09-04SaleGalectin Therapeutics Inc.
GALT
director
11,900
0.0292%
$6.58$78,256-29.2%
2018-08-30SaleGalectin Therapeutics Inc.
GALT
director
58,100
0.1473%
$6.08$353,312-20.65%
2017-12-08PurchaseGalectin Therapeutics Inc.
GALT
director
14,000
0.0301%
$1.85$25,943+95.68%
2017-11-16PurchaseCuris, Inc.
CRIS
director
25,000
0.0176%
$0.98$24,500-46.99%
2016-01-11PurchaseTitan Pharmaceuticals, Inc.
TTNP
Executive Chairman
5,000
0.027%
$3.25$16,250+66.67%
2015-08-28PurchaseTitan Pharmaceuticals, Inc.
TTNP
Executive Chairman
50,000
0.046%
$0.71$35,750+17.14%
2014-10-09PurchaseTitan Pharmaceuticals, Inc.
TTNP
Executive Chairman
100,000
0.0893%
$0.48$48,200+38.78%
2013-12-04PurchaseGalectin Therapeutics Inc.
GALT
director
6,000
0.0357%
$8.69$52,140+30.03%
2013-06-17PurchaseTitan Pharmaceuticals, Inc.
TTNP
Executive Chairman
50,000
0.0604%
$0.45$22,690+45.56%
2011-11-18PurchaseTitan Pharmaceuticals, Inc.
TTNP
Executive Chairman
38,400
3.661%
$1.27$48,918-36.22%
2011-10-18PurchaseGalectin Therapeutics Inc.
GALT
director
40,000
0.055%
$0.96$38,400-47.08%
2010-12-10PurchaseCuris, Inc.
CRIS
director
26,596
0.0355%
$1.89$50,266+73.55%
2008-02-07PurchaseTitan Pharmaceuticals, Inc.
TTNP
President & Chief Ex Officer
5,000
0.0115%
$1.30$6,514-64.62%
2008-02-06PurchaseTitan Pharmaceuticals, Inc.
TTNP
President & Chief Ex Officer
15,000
0.0349%
$1.31$19,700-64.06%
2008-02-05PurchaseTitan Pharmaceuticals, Inc.
TTNP
President & Chief Ex Officer
10,000
0.023%
$1.38$13,800-66.67%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.